金陵药业：交易性金融资产主要是银行结构性存款

Group 1 - The core viewpoint of the article is that Jinling Pharmaceutical (000919) clarified its financial asset composition and liquidity status in response to investor inquiries [1] - The company holds 1 billion in trading financial assets, primarily in structured bank deposits, and only has shares in Zijin Bank [1] - The total cash balance reported is 1.3 billion, which includes funds held by the company and its subsidiaries [1]